Vasoactive Adrenergic Meds - VASOPRESSORS Flashcards
PHENYLEPHRINE (NEOSYNEPHRINE) - a.k.a. “Neo”
Receptors
Pure Alpha-1
PHENYLEPHRINE (NEOSYNEPHRINE) - a.k.a. “Neo”
Effects
vasoconstriction so an increase in SVR and BP; may also cause reflex bradycardia; mixed effects on cardiac output
PHENYLEPHRINE (NEOSYNEPHRINE) - a.k.a. “Neo”
Concentration, Onset, Titrate, Dose
Concentration: 20 mg/250 ml or 40 mg/250 ml
Onset: 1 min
Titrate: Q3-5 min
Dose: 50-200 mcg/min (varies by hospital)
PHENYLEPHRINE (NEOSYNEPHRINE) - a.k.a. “Neo”
Area(s) of Effect
peripheral blood vessels (veno-arterial); smooth muscles
NOREPINEPHRINE (LEVOPHED) - a.k.a. “Levo”
Receptors
(+++) ALPHA - 1 (++) BETA - 1
NOREPINEPHRINE (LEVOPHED) - a.k.a. “Levo”
Effects
vasoconstriction so an increase SVR, BP, HR, contractility, AV node conduction
NOREPINEPHRINE (LEVOPHED) - a.k.a. “Levo”
Concentration, Onset, Titrate, Dose
Concentration: 4 mg/250 ml (also 2mg, 8mg, 16mg all in 250 ml)
Onset: 1 minute
Titrate: Q3-5 min
Dose: 1-12 mcg/min (varies by hospital)
NOREPINEPHRINE (LEVOPHED) - a.k.a. “Levo”
Area(s) of Effects
blood vessels (veno-arterial)
ISOPROTERENOL
Receptors
pure (+++) Beta-1; (+++) Beta-2
ISOPROTERENOL
Effects
increase HR, less effect on contractility, increase CO, mixed effect on BP
ISOPROTERENOL
Concentration, Onset, Titrate, Dose
Concent:
Onset: 1-5 min
Titrate:
Dose: 0.5-30 mcg/min
ISOPROTERENOL
Area(s) of Effects
heart, peripheral vessels, smooth muscle
EPINEPHRINE (ADRENALIN) - used in codes; last resort treatment for shock
Receptors
nonselective (mostly beta-1, beta-2, alpha-1)
mostly (+++) BETA - 1 (++) BETA - 2
low/high dose (+/++) ALPHA - 1
EPINEPHRINE (ADRENALIN) - used in codes; last resort treatment for shock
Effects
Vasoconstriction, increase HR. Increase BP is not as much as levo effects; varied effects on SVR.
EPINEPHRINE (ADRENALIN) - used in codes; last resort treatment for shock
Concentration, Onset, Titration, Dose
Concentration: 1 mg/250 ml
Onset: 1-2 min
Titrate: Q5-10 min
Dose: 1-10 mcg/min
(varies at hospitals;
more beta effects at lower doses,
more alpha effects at higher doses
DOPAMINERGIC Receptor (Agonist)
~increases BP and cardiac activity
~vasodilation in renal system
DOPAMINE
Receptors
(+/++) beta-1; (++) dopamine
*(also some alpha)
Low Dose - stimulates dopamine
Interm Dose - stimulates beta-1
High Dose - stimulates alpha
DOPAMINE
Effects
~Vasoconstriction at higher doses so
increases SVR, BP—some increase
in HR and CO.
~Low doses: vasodilate
DOPAMINE
Concentration, Onset, Titrate, Dose
Concentration: 400 mg/250 ml
Onset: 5 min
Titrate: Q10 min
Dose: 2-20 mcg/kg/min
(varies at hospitals)
renal effects (0.5-2)
inc. contractility (2-10)
*larger doses metabolized into norepinephrine causing more vasoconstriction than contractility
DOPAMINE
Area(s) of Effects
heart; peripheral vessels; renal
DOBUTAMINE
Receptors
both Beta-1 and Beta-2
(a little of alpha)
DOBUTAMINE
Effect(s)
~inc. HR, CO, contractility (beta-1) but
minimal BP increase
~dec. SVR because of vasodilation
DOBUTAMINE
Area(s) of Effect
heart and peripheral vessels
DOBUTAMINE
Concentration, Onset, Titrate, Dose
Concent: 250 mg/250 ml
(500 mg/250 ml)
Onset: 1-2 min
Titrate: Q10 min
Dose: 2-20 mcg/kg/min